Figures & data
Figure 1 Overview of nanoparticle-based strategies for the treatment and prevention of myocardial infarction. Nanoparticles are capable of delivering therapeutic agents and nucleic acids in a stable and targeted manner, improving the properties of tissue engineering scaffolds, labeling transplanted cells and regulating cell behaviors, thus promoting the cardioprotective effects of traditional or novel therapies.
![Figure 1 Overview of nanoparticle-based strategies for the treatment and prevention of myocardial infarction. Nanoparticles are capable of delivering therapeutic agents and nucleic acids in a stable and targeted manner, improving the properties of tissue engineering scaffolds, labeling transplanted cells and regulating cell behaviors, thus promoting the cardioprotective effects of traditional or novel therapies.](/cms/asset/fa689657-9832-4ae0-b5e7-99ebecf4fd4c/dijn_a_12192524_f0001_c.jpg)
Table 1 NPs-Based Drug Delivery Systems for Treatment for MI Reported in the Last 7 Years
Table 2 NPs-Based Nucleic Acid Delivery Systems for Treatment for MI Reported in the Last 7 Years
Table 3 Studies Combining NPs and Cell Therapy Reported in the Last 7 Years
Table 4 NPs-Based Preventive Strategies for MI Reported in the Last 7 Years